Strongbridge Biopharma plc
SBBP · NASDAQ
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Market Cap | $136,336 | $115,751 | $222,766 | $264,950 |
| - Cash | $87,522 | $57,032 | $122,490 | $57,510 |
| + Debt | $18,194 | $1,454 | $0 | $37,794 |
| Enterprise Value | $67,008 | $60,173 | $100,276 | $245,234 |
| Revenue | $30,731 | $21,712 | $18,027 | $7,046 |
| % Growth | 41.5% | 20.4% | 155.8% | – |
| Gross Profit | $28,519 | $17,890 | $14,041 | $5,563 |
| % Margin | 92.8% | 82.4% | 77.9% | 79% |
| EBITDA | -$38,647 | -$42,584 | $52,135 | -$102,367 |
| % Margin | -125.8% | -196.1% | 289.2% | -1,452.8% |
| Net Income | -$45,075 | -$49,451 | $31,851 | -$113,483 |
| % Margin | -146.7% | -227.8% | 176.7% | -1,610.6% |
| EPS Diluted | -0.8 | -0.89 | 0.64 | -3.11 |
| % Growth | 10.1% | -239.1% | 120.6% | – |
| Operating Cash Flow | -$38,134 | -$44,784 | -$84,576 | -$45,336 |
| Capital Expenditures | -$10 | -$74 | -$326 | $0 |
| Free Cash Flow | -$38,144 | -$44,858 | -$84,902 | -$45,336 |